ACCELERATE DS-813 is a modified cellulose gum that can be used in the pharmaceutical industry. ACCELERATE DS-813 meets the requirements for residual solvents in the United States Pharmacopeia and complies with the ICH Guide Q3C for residual solvents. It has a loss on drying of less than 10% and pH range of 5.0 to 7.0 making it suitable for use in pharmaceutical applications. ACCELERATE DS-813 has a total degree of substitution of 0.60 to 0.85 and settling volume of 10.0 to 30.0 ml, meeting the specifications for pharmaceutical grade modified cellulose gums. Its hygroscopic nature and ability to meet regulatory standards make ACCELERATE DS-813 a reliable excipient choice for the pharmaceutical industry.